Your Article Summary
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 10/23/09
Chugai Pharmaceutical Co., Ltd., announced today that a New Drug Application was filed to the Ministry of Health, Labour and Welfare for the active vitamin D3 derivative which was discovered by Chugai and co–developed by the two companies for the indication of osteoporosis.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Article Search
Sponsor


See Latest Articles


